Monday 12 October 2026 Export all AMGN data to Excel Powerpack

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

414.87 7.43 +1.82%
Market cap
$220.3B
P/E
25.6×
Fwd P/E
22.7×
Dividend yield
2.40%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
22.33 24.30 22.84 21.66

+8 more quarters

P/S ratio
5.13 5.10 4.79 4.22
P/FCF ratio
20.07 23.28 22.97 13.67
P/Operating CF
48.86 86.80 109.85 32.41
P/B ratio
16.73 20.67 20.34 15.78
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
6.27 6.32 6.03 5.48
EV/EBITDA
14.48 14.83 14.34 12.85
EV/Operating CF
19.14 21.87 22.25 15.01
EV/FCF
24.52 28.82 28.90 17.74
Quick Ratio
0.95 0.85 0.73 0.82
Current Ratio
1.37 1.26 1.14 1.28
Net Debt/EBITDA
9.36 11.97 11.81 10.66
Debt/Assets
59.92% 61.97% 60.28% 60.56%
Debt/Equity
4.90 6.24 6.31 5.67
Asset Turnover
0.42 0.41 0.40 0.40
Operating CF/Net income
1.69 1.20 1.20 1.46
Capex/Depreciation
(0.46) (0.64) (0.57) (0.26)
Interest Coverage
5.22 4.06 4.17 3.69
Research and Development Expense of Revenue
18.58% 19.95% 21.71% 19.88%
Selling, General and Administrative Expense of Revenue
17.36% 18.59% 19.79% 18.00%
Intangible Assets out of Total Assets
0.41 0.43 0.45 0.46
Share Based Compensation of Revenue
1.64% 0.87% 1.27% 1.33%
Graham Net Nets
(0.25) (0.27) (0.30) (0.35)
Graham Number
88.88 74.46 72.03 72.40
Earnings Yield
4.48% 4.12% 4.38% 4.62%
Free Cash Flow Yield
4.98% 4.30% 4.35% 7.31%
Revenue per Share
18.62 15.96 18.34 17.76
Operating CF per Share
7.41 4.05 2.98 8.71
Capex per Share
(0.95) (1.32) (1.19) (0.81)
Free Cash Flow per Share
6.46 2.74 1.79 7.90
Cash per Share
25.91 22.29 16.97 17.56
Shareholders Equity per Share
21.64 17.02 16.09 17.88
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
21.64 17.02 16.09 17.88
Free Cash Flow
3,489.00 1,477.00 961.00 4,248.00
Working Capital
9,459.00 6,520.00 3,568.00 6,094.00
Capital Expenditures
(513.00) (712.00) (642.00) (436.00)
Net Current Asset Value
(48,990.00) (51,839.00) (52,871.00) (52,637.00)
EV/EBIT
20.90 22.26 24.40 22.72
Capex to Sales
0.05 0.08 0.07 0.05
Price to Operating Income
17.11 17.98 19.39 17.51
Other line items
Average Receivables
9,464.00 8,635.00 8,176.00 7,903.50
Average Payables
2,937.50 2,670.50 2,137.50 2,492.50
Average Inventory
6,401.50 6,457.50 6,611.50 6,854.00
Average Assets
91,768.00 90,935.50 91,212.50 90,512.00
Average Common Equity
9,558.00 7,698.50 7,267.50 8,573.00

Fold the line items

Columns are period end dates